首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Pharmacokinetics and effects on serum cholinesterase activities of organophosphorus pesticides acephate and chlorpyrifos in chimeric mice transplanted with human hepatocytes
【24h】

Pharmacokinetics and effects on serum cholinesterase activities of organophosphorus pesticides acephate and chlorpyrifos in chimeric mice transplanted with human hepatocytes

机译:有机磷农药乙酰甲胺磷和毒死rif对人肝细胞移植小鼠的药代动力学及其对血清胆碱酯酶活性的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Organophosphorus pesticides acephate and chlorpyrifos in foods have potential to impact human health. The aim of the current study was to investigate the pharmacokinetics of acephate and chlorpyrifos orally administered at lowest-observed-adverse-effect-level doses in chimeric mice transplanted with human hepatocytes. Absorbed acephate and its metabolite methamidophos were detected in serum from wild type mice and chimeric mice orally administered 150 mg/kg. Approximately 70% inhibition of cholinesterase was evident in plasma of chimeric mice with humanized liver (which have higher serum cholinesterase activities than wild type mice) 1 day after oral administrations of acephate. Adjusted animal biomonitoring equivalents from chimeric mice studies were scaled to human biomonitoring equivalents using known species allometric scaling factors and in vitro metabolic clearance data with a simple physiologically based pharmacokinetic (PBPK) model. Estimated plasma concentrations of acephate and chlorpyrifos in humans were consistent with reported concentrations. Acephate cleared similarly in humans and chimeric mice but accidental/incidental overdose levels of chlorpyrifos cleared (dependent on liver metabolism) more slowly from plasma in humans than it did in mice. The data presented here illustrate how chimeric mice transplanted with human hepatocytes in combination with a simple PBPK model can assist evaluations of toxicological potential of organophosphorus pesticides. (C) 2014 Elsevier Inc. All rights reserved.
机译:食品中的有机磷农药乙酰甲酸酯和毒死rif有可能影响人类健康。本研究的目的是研究以最低观察到的不良作用水平口服口服乙酰甲胺磷和毒死rif对移植有人类肝细胞的嵌合小鼠的药代动力学。从野生型小鼠和口服口服150 mg / kg的嵌合小鼠的血清中检测到吸收的乙酰甲酸酯及其代谢物甲胺磷。口服乙酰乙酸后1天,在人源化肝脏嵌合小鼠(其血清胆碱酯酶活性高于野生型小鼠)的血浆中,胆碱酯酶的抑制作用约为70%。使用已知的物种异速缩放比例因子和具有简单的基于生理学的药代动力学(PBPK)模型的体外代谢清除率数据,将来自嵌合小鼠研究的调整后的动物生物等效物换算成人类生物等效物。估计的人体内乙酰乙酸盐和毒死rif的血浆浓度与报道的浓度一致。在人类和嵌合体小鼠中,乙酰乙酸盐清除的方式相似,但是人血浆中毒死rif的意外/偶然过量清除(取决于肝脏代谢)的速度比小鼠中清除的速度慢。此处提供的数据说明了将人肝细胞与简单的PBPK模型结合移植的嵌合小鼠如何帮助评估有机磷农药的毒理学潜力。 (C)2014 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号